Biotheranostics presents new studies of the Breast Cancer Index® at the 2020 ASCO conference, expanding its clinical utility as a ...
San Diego, CA, May 29, 2020 (GLOBE NEWSWIRE) -- Biotheranostics announces several new studies demonstrating comprehensive validation and clinical utility of its Breast Cancer Index genomic assay for early-stage, HR+ breast cancer that will be presented at …